CAS.NO: 116094-23-6

Insulin Aspart is a biosynthetic fast-acting human insulin analog by substituting aspartic acid for proline at position 28 of the B chain of human insulin, which can significantly reduce postprandial blood glucose in the treatment of typeⅠand typeⅡ diabetes, and the risk of hypoglycemia, especially nighttime hypoglycemia, is significantly reduced.

Insulin Aspart Recommended Method

instant acting insulin acting easy dissolved in acidic (pH